| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9227214 | Journal of Allergy and Clinical Immunology | 2005 | 5 Pages |
Abstract
The early response to inhaled allergen was unchanged after desloratadine therapy and partially inhibited with montelukast therapy. The combination of desloratadine and montelukast provided superior efficacy to either blocker administered alone. Investigations into the possible mechanisms of the enhanced inhibition are necessary.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Beth E. BSc, David C. MD, FRCP(C), Donald W. MD, FRCP(C),